Literature DB >> 23226576

NSP-CAS Protein Complexes: Emerging Signaling Modules in Cancer.

Yann Wallez1, Peter D Mace, Elena B Pasquale, Stefan J Riedl.   

Abstract

The CAS (CRK-associated substrate) family of adaptor proteins comprises 4 members, which share a conserved modular domain structure that enables multiple protein-protein interactions, leading to the assembly of intracellular signaling platforms. Besides their physiological role in signal transduction downstream of a variety of cell surface receptors, CAS proteins are also critical for oncogenic transformation and cancer cell malignancy through associations with a variety of regulatory proteins and downstream effectors. Among the regulatory partners, the 3 recently identified adaptor proteins constituting the NSP (novel SH2-containing protein) family avidly bind to the conserved carboxy-terminal focal adhesion-targeting (FAT) domain of CAS proteins. NSP proteins use an anomalous nucleotide exchange factor domain that lacks catalytic activity to form NSP-CAS signaling modules. Additionally, the NSP SH2 domain can link NSP-CAS signaling assemblies to tyrosine-phosphorylated cell surface receptors. NSP proteins can potentiate CAS function by affecting key CAS attributes such as expression levels, phosphorylation state, and subcellular localization, leading to effects on cell adhesion, migration, and invasion as well as cell growth. The consequences of these activities are well exemplified by the role that members of both families play in promoting breast cancer cell invasiveness and resistance to antiestrogens. In this review, we discuss the intriguing interplay between the NSP and CAS families, with a particular focus on cancer signaling networks.

Entities:  

Keywords:  SRC kinase; antiestrogen resistance; invasion; migration; serine phosphorylation; tyrosine phosphorylation

Year:  2012        PMID: 23226576      PMCID: PMC3513790          DOI: 10.1177/1947601912460050

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  122 in total

1.  Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity.

Authors:  Jean-François Côté; Kristiina Vuori
Journal:  J Cell Sci       Date:  2002-12-15       Impact factor: 5.285

Review 2.  Regulation of integrin-mediated cellular responses through assembly of a CAS/Crk scaffold.

Authors:  David Chodniewicz; Richard L Klemke
Journal:  Biochim Biophys Acta       Date:  2004-07-05

3.  JNK phosphorylates paxillin and regulates cell migration.

Authors:  Cai Huang; Zenon Rajfur; Christoph Borchers; Michael D Schaller; Ken Jacobson
Journal:  Nature       Date:  2003-07-10       Impact factor: 49.962

4.  p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells.

Authors:  Anna C Cunningham-Edmondson; Steven K Hanks
Journal:  Breast Cancer (Dove Med Press)       Date:  2009-12-07

5.  p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.

Authors:  Michael K Wendt; Jason A Smith; William P Schiemann
Journal:  J Biol Chem       Date:  2009-10-12       Impact factor: 5.157

6.  Expression of a phosphorylated p130(Cas) substrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells.

Authors:  Shefali Soni; Bor-Tyh Lin; Avery August; Robert I Nicholson; Kathrin H Kirsch
Journal:  J Cell Biochem       Date:  2009-05-15       Impact factor: 4.429

7.  The SH2 and SH3 domains of pp60src direct stable association with tyrosine phosphorylated proteins p130 and p110.

Authors:  S B Kanner; A B Reynolds; H C Wang; R R Vines; J T Parsons
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

8.  CAS/Crk coupling serves as a "molecular switch" for induction of cell migration.

Authors:  R L Klemke; J Leng; R Molander; P C Brooks; K Vuori; D A Cheresh
Journal:  J Cell Biol       Date:  1998-02-23       Impact factor: 10.539

9.  Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.

Authors:  Lambert C J Dorssers; Ton van Agthoven; Arend Brinkman; Jos Veldscholte; Marcel Smid; Koen J Dechering
Journal:  Breast Cancer Res       Date:  2004-11-16       Impact factor: 6.466

10.  Loss of AND-34/BCAR3 expression in mice results in rupture of the adult lens.

Authors:  Richard I Near; Richard S Smith; Paul A Toselli; Thomas F Freddo; Alexander B Bloom; Pierre Vanden Borre; David C Seldin; Adam Lerner
Journal:  Mol Vis       Date:  2009-04-03       Impact factor: 2.367

View more
  11 in total

1.  Loss of PTPN12 Stimulates Progression of ErbB2-Dependent Breast Cancer by Enhancing Cell Survival, Migration, and Epithelial-to-Mesenchymal Transition.

Authors:  Juan Li; Dominique Davidson; Cleiton Martins Souza; Ming-Chao Zhong; Ning Wu; Morag Park; William J Muller; André Veillette
Journal:  Mol Cell Biol       Date:  2015-09-21       Impact factor: 4.272

Review 2.  Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.

Authors:  Elena Shagisultanova; Anna V Gaponova; Rashid Gabbasov; Emmanuelle Nicolas; Erica A Golemis
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

Review 3.  Embryonal Fyn-associated substrate (EFS) and CASS4: The lesser-known CAS protein family members.

Authors:  Alexander Deneka; Vladislav Korobeynikov; Erica A Golemis
Journal:  Gene       Date:  2015-06-26       Impact factor: 3.688

4.  Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes.

Authors:  Ana Carolina Pavanelli; Flavia Rotea Mangone; Piriya Yoganathan; Simone Aparecida Bessa; Suely Nonogaki; Cynthia A B de Toledo Osório; Victor Piana de Andrade; Iberê Cauduro Soares; Evandro Sobrosa de Mello; Lois M Mulligan; Maria Aparecida Nagai
Journal:  Breast Cancer Res Treat       Date:  2022-01-15       Impact factor: 4.872

5.  Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.

Authors:  Yann Wallez; Stefan J Riedl; Elena B Pasquale
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

Review 6.  CAS proteins in health and disease: an update.

Authors:  Anna S Nikonova; Anna V Gaponova; Alexander E Kudinov; Erica A Golemis
Journal:  IUBMB Life       Date:  2014-06-24       Impact factor: 3.885

7.  Expression pattern of bcar3, a downstream target of Gata2, and its binding partner, bcar1, during Xenopus development.

Authors:  Yangsook Song Green; Sunjong Kwon; Jan L Christian
Journal:  Gene Expr Patterns       Date:  2015-11-26       Impact factor: 1.224

Review 8.  XB130-A Novel Adaptor Protein: Gene, Function, and Roles in Tumorigenesis.

Authors:  Xiao-Hui Bai; Hae-Ra Cho; Serisha Moodley; Mingyao Liu
Journal:  Scientifica (Cairo)       Date:  2014-06-05

9.  A Cas-BCAR3 co-regulatory circuit controls lamellipodia dynamics.

Authors:  Jason D Berndt; Carissa Pilling; Elizabeth M Steenkiste; Christopher Simpkins; Jonathan A Cooper
Journal:  Elife       Date:  2021-06-25       Impact factor: 8.140

Review 10.  The Role of Crk Adaptor Proteins in T-Cell Adhesion and Migration.

Authors:  Alex Braiman; Noah Isakov
Journal:  Front Immunol       Date:  2015-10-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.